Zobrazeno 1 - 10
of 30
pro vyhledávání: '"MESH: Hydroxymethylglutaryl-CoA Reductase Inhibitors"'
Autor:
Raluca Pais, Maxime Mallet
Publikováno v:
Alimentary Pharmacology & Therapeutics (Suppl)
Alimentary Pharmacology & Therapeutics (Suppl), 2021, 54 (11-12), pp.1499-1500. ⟨10.1111/apt.16675⟩
Alimentary Pharmacology & Therapeutics (Suppl), 2021, 54 (11-12), pp.1499-1500. ⟨10.1111/apt.16675⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63670ff4f6f953aa64fd14902b2a57a7
https://doi.org/10.1111/apt.16675
https://doi.org/10.1111/apt.16675
Publikováno v:
Hepatology
Hepatology, Wiley-Blackwell, 2021, 73 (2), pp.875. ⟨10.1002/hep.31511⟩
Hepatology (Baltimore, Md.)
Hepatology, Wiley-Blackwell, 2021, 73 (2), pp.875. ⟨10.1002/hep.31511⟩
Hepatology (Baltimore, Md.)
Coronavirus disease 2019 (COVID-19) leads to elevated liver biochemistries in approximately half of patients on presentation. To date, data are limited regarding the trend of liver biochemistries over the course of illness. We aimed to evaluate the t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::454f0e3b5e3869b9498a60172dca0d1d
https://hal.umontpellier.fr/hal-03367867
https://hal.umontpellier.fr/hal-03367867
Autor:
Etienne Puymirat, Nicolas Danchin, Yves Cottin, Nadia Aissaoui, Tabassome Simon, Jean Ferrières, Gilles Lemesle, Francois Schiele, Pierre Coste
Publikováno v:
American Journal of Cardiology
American Journal of Cardiology, Elsevier, 2017, 119 (5), pp.692-697. ⟨10.1016/j.amjcard.2016.11.032⟩
American Journal of Cardiology, Elsevier, 2017, 119 (5), pp.692-697. 〈http://www.sciencedirect.com/science/article/pii/S0002914916319014〉. 〈10.1016/j.amjcard.2016.11.032〉
American Journal of Cardiology, 2017, 119 (5), pp.692-697. ⟨10.1016/j.amjcard.2016.11.032⟩
American Journal of Cardiology, Elsevier, 2017, 119 (5), pp.692-697. ⟨10.1016/j.amjcard.2016.11.032⟩
American Journal of Cardiology, Elsevier, 2017, 119 (5), pp.692-697. 〈http://www.sciencedirect.com/science/article/pii/S0002914916319014〉. 〈10.1016/j.amjcard.2016.11.032〉
American Journal of Cardiology, 2017, 119 (5), pp.692-697. ⟨10.1016/j.amjcard.2016.11.032⟩
IF 3.398; International audience; The prognosis of patients with acute myocardial infarction (AMI) has notably improved in the past 20 years. Using the French Registry of ST-Elevation and Non-ST-elevation Myocardial Infarction (FAST-MI) 2010 registry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2702a860b709cf8b2ee2cc47000590e1
https://doi.org/10.1016/j.amjcard.2016.11.032
https://doi.org/10.1016/j.amjcard.2016.11.032
Autor:
Nicolas Danchin, Tabassome Simon
Publikováno v:
European Heart Journal-Cardiovascular Pharmacotherapy
European Heart Journal-Cardiovascular Pharmacotherapy, Oxford Academy, 2020, 6 (5), pp.328-330. ⟨10.1093/ehjcvp/pvz049⟩
European Heart Journal-Cardiovascular Pharmacotherapy, Oxford Academy, 2020, 6 (4), pp.328-330. ⟨10.1093/ehjcvp/pvz049⟩
European Heart Journal — Cardiovascular Pharmacotherapy
European Heart Journal-Cardiovascular Pharmacotherapy, Oxford Academy, 2020, 6 (5), pp.328-330. ⟨10.1093/ehjcvp/pvz049⟩
European Heart Journal-Cardiovascular Pharmacotherapy, Oxford Academy, 2020, 6 (4), pp.328-330. ⟨10.1093/ehjcvp/pvz049⟩
European Heart Journal — Cardiovascular Pharmacotherapy
International audience; Full secondary prevention medication regimen is often under-prescribed after acute myocardial infarction.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e4d70c11d85bdc0174d28780b7298a8
https://hal.archives-ouvertes.fr/hal-03028540
https://hal.archives-ouvertes.fr/hal-03028540
Autor:
HAUBER, Claire
Publikováno v:
Médecine humaine et pathologie. 2019
Objectif : le profil d’efficacité et de sécurité des statines est régulièrement débattu dans les média bien que ces traitements soient recommandés en prévention de la survenue ou récidive d’évènements cardiovasculaires ischémiques. L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2592::ae37e9504dd5293530304518eb7217bd
https://dumas.ccsd.cnrs.fr/dumas-02506529/file/ThExe_HAUBER_Claire_DUMAS.pdf
https://dumas.ccsd.cnrs.fr/dumas-02506529/file/ThExe_HAUBER_Claire_DUMAS.pdf
Autor:
Coumar, Ouma-Cécilia
Publikováno v:
Médecine humaine et pathologie. 2019
Objectives: statins are treatments reducing cardiovascular disease and overall mortality in patients for the secondary and primary prevention. Although generally safe and well tolerated, statin therapy may cause myopathy, but long-term effects on hea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2592::90d5e243e40b9d531167d7257c9ed7e9
https://dumas.ccsd.cnrs.fr/dumas-03149654/document
https://dumas.ccsd.cnrs.fr/dumas-03149654/document
Autor:
Michele Wood, Kari L. Olson, Anne M. Denham, Sheila L. Stadler, Roseanne Hornak, Leslie K. Ruppe, Thomas Delate
Publikováno v:
Pharmacy Practice
Pharmacy Practice (Granada), Volume: 17, Issue: 2, Article number: 1402, Published: 18 NOV 2019
Pharmacy Practice, Vol 17, Iss 2, p 1402 (2019)
Pharmacy Practice (Granada) v.17 n.2 2019
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Pharmacy Practice (Granada), Volume: 17, Issue: 2, Article number: 1402, Published: 18 NOV 2019
Pharmacy Practice, Vol 17, Iss 2, p 1402 (2019)
Pharmacy Practice (Granada) v.17 n.2 2019
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Background: High intensity statin therapy (HIST) is the gold standard therapy for decreasing the risk of recurrent atherosclerotic cardiovascular disease (ASCVD); however, little is known about the use of HIST in older adults with ASCVD. Objectives:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b8091a20598af7663adb8ddd5b5aeda
https://doi.org/10.18549/pharmpract.2019.2.1402
https://doi.org/10.18549/pharmpract.2019.2.1402
Publikováno v:
Thrombosis Research
Thrombosis Research, Elsevier, 2008, 122 (3), pp.314-9. ⟨10.1016/j.thromres.2007.10.014⟩
Thrombosis Research, Elsevier, 2008, 122 (3), pp.314-9. ⟨10.1016/j.thromres.2007.10.014⟩
International audience; BACKGROUND: Previous studies reported that statin use was associated with a decreased risk of venous thromboembolism (VTE), whereas no association was found between fibrate use and VTE. This report aims to test the hypothesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a49646a991cf06cf6a9ef1898348f82
https://doi.org/10.1016/j.thromres.2007.10.014
https://doi.org/10.1016/j.thromres.2007.10.014
Autor:
Grégoire Le Gal, Stéphanie Louis, Francis Couturaud, Karine Lacut, Emmanuel Oger, Christophe Leroyer, Dominique Mottier
Publikováno v:
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2004, 18 (4), pp.477-82. ⟨10.1111/j.1472-8206.2004.00252.x⟩
Fundamental and Clinical Pharmacology, Wiley, 2004, 18 (4), pp.477-82. ⟨10.1111/j.1472-8206.2004.00252.x⟩
International audience; Previous studies of selected patients have suggested a reduction in the risk of venous thromboembolism with the use of statins. The objective of this study is to evaluate the influence of statin use on the risk of venous throm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59ba474fb4fa96efe34b402b3abdb972
https://doi.org/10.1111/j.1472-8206.2004.00252.x
https://doi.org/10.1111/j.1472-8206.2004.00252.x
Publikováno v:
Diabetes Research and Clinical Practice
Diabetes Research and Clinical Practice, Elsevier, 2009, 84 (2), pp.138-44
Diabetes Research and Clinical Practice, Elsevier, 2009, 84 (2), pp.138-44
International audience; AIMS: The effect of a cardiovascular rehabilitation program on arterial compliance in type 2 diabetes mellitus with coronary disease was studied. METHODS: Hemodynamic data and arterial compliance were measured with a tonometer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b76160608526443652201016c72fcb15
https://hal.archives-ouvertes.fr/hal-00452052
https://hal.archives-ouvertes.fr/hal-00452052